Holly Vance
About Holly Vance
Holly Vance's Current Titles
Holly Vance is currently serving as the Chief Operating Officer and Chief Legal Officer. In her dual roles, she is responsible for overseeing the operational functions of the organization while also providing top-tier legal counsel. Her expertise combines both operational management and legal strategy, aiding in both the day-to-day functions and long-term legal planning of the organization.
Holly Vance's Previous Role at Neoleukin Therapeutics
Before her current position, Holly Vance served as the General Counsel at Neoleukin Therapeutics. In this role, she was responsible for leading the company's legal department, ensuring compliance with legal regulations, and providing strategic legal advice to the executive team. Her legal expertise was pivotal in guiding the company through various legal challenges and opportunities.
Holly Vance's Contributions to the Bill & Melinda Gates Foundation
Holly Vance provided legal and strategic guidance at the Bill & Melinda Gates Foundation, where she played a crucial role in advising on legal matters related to the foundation's mission and initiatives. Her legal insights supported the foundation in navigating complex legal landscapes and ensuring the integrity of its philanthropic efforts.
Holly Vance's Legal Career at K&L Gates
As a partner at K&L Gates law firm in Seattle, Holly Vance gained extensive experience in legal practice. Her role involved representing clients in various legal matters, advising on corporate governance, and contributing to the firm's strategic direction. Her tenure at K&L Gates provided her with valuable insights and experience that have been instrumental in her subsequent roles.
Holly Vance's Educational Background
Holly Vance has an impressive academic background with three degrees from the University of Washington. She received a J.D. from the University of Washington School of Law, a Pharm.D. from the University of Washington School of Pharmacy, and a B.S. degree in Cell and Molecular Biology from the University of Washington. Her diverse educational qualifications have equipped her with a unique blend of legal, pharmaceutical, and scientific expertise.